<p>Effective Inhibition of <em>MYC</em>-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1</p>
Cited by 6
Related Papers
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
|Journal of Experimental & Clinical Cancer Research|2018|40